Biotech News: Mirror to Biotech Academia & Industry

Biotech news from India and across the globe. One stop site for your daily dose of Biotech industry , academia news and latest collaborations

Accelerator Corp., the biotechnology investment and management company that has nurtured biotech startups in Seattle for more than a decade, is expanding its activity to New York City through a new

The NIH has granted 23andMe $1,367,504 for a two-year project to enhance further development of the personal genetics firm's web-based database and research engine for genetic discovery.

MIT researchers attained a major breakthrough as they discovered a mechanism by which the particles enter cells and could thus act as better drug carriers.

Life Cell, India's largest umbilical cord banking system is all set to establish a public stem cell bank at a cost of Rs 30,000 crore to save millions of children by saving their stem c

A latest research revealed on how viruses called bacteriophages destroy the bacterium Clostridium difficile (C.

An initiative to enhance access to biotech innovations in various verticals like marine, pharmaceuticals, agricultural and industries under a one-roof facility has been started by the state governm

"Organ-on-chips" would now be commercialized by Harvard's Wyss Institute for Biologically Inspired Engineering as they created a startup called Emulate which plans on focusing on the

Claiming a wrong decision and a step deterring investments in research and high quality manufacturing and distribution, Kiran Mazumdar Shaw, chairman and managing director Biocon Limited and Chairp

A deal buttressing on the existing mutual relationship, Bristol-Myers Squibb ($BMY) and Ono Pharmaceutical have inked a pact to bring immunotherapies to market in Japan, South Korea and Taiwan.

Atox Bio is a clinical stage biotechnology company and a developer of therapeutics for severe infections, based in Israel.

In a recent development AstraZeneca signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung

The regulatory bodies of the U.S have accepted the application by Sandoz-generics arms of Novartis which was seeking approval for a copycat version of Amgen's drug Neupogen, or filgrast

Qiagen achieved a major feat by grabbing an exclusive global license from the University of Tokyo for the biomarker SF3B1.

Scientists from Oxford University revealed that only 8.2% of human DNA is likely to be doing something important, i.e., is functional.

A new study led by researchers at San Diego State University has found that more than half the world’s population is host to a newly described virus, named crAssphage, which infects o

An effort to primarily improve the delivery of world-class cancer care services has been put forward by Fortis Healthcare Limited.

If your job search strategy keeps running into a brick wall whenever you send out your executive resume, or you’re repeatedly receiving phone calls for lower paying

Boehringer Ingelheim, through the Toronto Recombinant Antibody Centre (TRAC),  established a research alliance with the University of Toronto, the University Health Network, and Mount Sin

Shire plc, a the global specialty biopharmaceutical company and ArmaGen, US-based privately held biotechnology company announced a worldwide licensing and collaboration agreement for AGT-18

In a recent deal, China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services

The two big pharma majors, Sun Pharma and Ranbaxy merge to create US$ 4 billion Indian pharma entity which would be the largest Pharmaceutical company in India post merger.

In the 11th Presidential Advisory Council on Science and Technology held in Hawolgok-dong, Seoul on July 17, the Korean government announced plans to boost the fast growing biotech sector o

The various obstructions pertaining to supply in platelets such as small life shell of five days, high risks of contamination, infection, and rejection have been plaguing and disappointing

MedImmune, a global biologics research and development arm of AstraZeneca, has entered into a clinical trial collaboration with Advaxis, Inc., a US-based biotechnology company developing cancer imm